DSTL holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 100% at a quoted market price (level 1), 3 issuer countries.

DSTL's largest investment is AbbVie Inc at 3.35% of net assets. Merck & Co Inc and Qualcomm Inc follow; the three together are 8.67%. Ten companies are 20.08% of the fund; the other 98 share the rest. Among the 721 equity funds measured here, DSTL behaves like 85.6 holdings against a median of 42.4 — 2.0 times the median. Across 26 quarterly filings DSTL has become less concentrated: it behaved like 66.7 at 2020-03-31 and 85.6 at 2026-06-30. Between the 2026-03-31 and 2026-06-30 filings 8 positions were added and 1 dropped; 10.1% of the weight moved.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Between 2020-03-31 and 2026-06-30, DSTL went from behaving like 66.7 equally weighted positions to 85.6 — 28% more, while its top ten went from 26.07% to 20.08% of net assets. Read across the funds on the concentration-over-time table.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

The 15 largest of 108 positions in DSTL's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: DSTL.csv.gz.

Share of DSTL's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

Monthly total returns from Item B.5 of DSTL's own filings, 78 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference 0.06 percentage points over 78 months, which is roughly the distributions. Every month with the filing it came from: DSTL.json · all funds.

101 positions became 108: 8 added (3.5% of the fund at the later date), 1 dropped (1.1% at the earlier date). Half the sum of all weight changes, a turnover proxy: 10.1%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of DSTL compared this way, as a feed: changes.xml · all funds: filings received.

New: Devon Energy Corp (0.84%), Leidos Holdings Inc (0.41%), Tradeweb Markets Inc (0.41%), Tenet Healthcare Corp (0.39%), Tyler Technologies Inc (0.37%), Jazz Pharmaceuticals PLC (0.36%). Gone: Coterra Energy Inc (1.06%).

99.86% equity, 0.14% short-term investment as filed; 100.0% carried at a quoted market price (fair-value level 1). Categories and levels are the filer's; what a low level-1 share does and does not mean is in the measure's page.

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of DSTL (85.6). Same filings, same arithmetic. Position in this list says nothing about which fund is better.